Initial Public Offering
First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq.
Definition
An Initial Public Offering (IPO) is the first sale of a company's equity to public investors through a registered offering filed with the SEC under the Securities Act of 1933 (Form S-1). The process includes pre-filing organizational meetings, drafting the S-1 prospectus, SEC review, the road show, pricing, and listing on a national exchange (NYSE, Nasdaq). MedTech IPO windows are highly cyclical and typically require either commercial-stage revenue or late-stage clinical data with a near-term FDA decision.What this means in practice
For MedTech, the IPO is one of two primary liquidity paths (the other is M&A). Public-company readiness imposes ongoing 10-K, 10-Q, 8-K, SOX 404, and Reg FD obligations that materially change operating cost.- •Going public too early, public markets punish missed clinical or commercial milestones harshly.
- •Underestimating SOX 404(b) internal-control audit costs in the first post-IPO year.
Related terms
Shared paths + categoryValuation ratio applied at exit, e.g., enterprise value to revenue.
Transactions in which one company acquires or combines with another, the dominant MedTech exit path, typically a strategic acquisition by an established player.
Any transaction that converts illiquid private-company equity into cash or freely tradable securities, typically IPO, M&A, or secondary tender.
Ledger of all securities issued by a company and who owns them.
Short-term debt that converts into equity at a future financing round.
Investigation of a company before an investment, financing, or acquisition.
Latest in MedTech
Primary references
3 sources- 1SEC, Form S-1VerifiedSECsec.gov
- 2SEC, Going PublicVerifiedSECsec.gov
- 3Silicon Valley Bank - Healthcare ReportsVerifiedSVBsvb.com
Inline markers like [1] jump to the matching reference above.